Latest News

Pfizer shares sink on weak 2024 revenue, profit forecasts


In this article


Albert Bourla, chief executive officer of Pfizer Inc., speaks during China Development Forum (CDF) 2023 at Diaoyutai State Guesthouse on March 25, 2023 in Beijing, China. 
Lintao Zhang | Getty Images


Sales of Paxlovid and the vaccine Pfizer makes with German partner BioNTech

But a drop in annual vaccination rates and demand for the treatments in 2023 have forced the company to launch a program in October to cut jobs and expenses to save at least $4 billion a year.

The company, which employs nearly 83,000 employees globally, in November cut 500 jobs at its Sandwich, Kent site in the UK.

Pfizer also expects to complete the $43 billion acquisition of cancer drugmaker Seagen

The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts’ average estimate of $63.17 billion, according to LSEG data.

The company also forecast adjusted profit in the range of $2.05 to $2.25 per share, lower than analysts’ expectation of $3.16.

Mortgage refinance demand jumps 19% after rates hit lowest level since July

Previous article

Cathie Wood Sails Past Fidelity Thanks To A Hail Mary Stock Pick

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News